Dr Reddy's Labs (DRL) is expected to report a profit after tax of Rs 270 crore for the second quarter of FY12, a fall of 6% as compared to Rs 286.8 crore in the corresponding quarter of last fiscal, as per IFRS.
Revenues are seen going up by 12% to Rs 2,096 crore from Rs 1,870 crore and EBITDA too is likely to go up by 20% to Rs 387 crore from Rs 323 crore year-on-year.
Operating profit margin is seen improving at 18% in the July-September quarter of FY12 as against 17.3% in same quarter the previous year and 14% in the previous quarter.
On quarter-on-quarter basis, DRL's revenues are expected to jump 6% and EBITDA to rise by 38%. Profit after tax is likely to increase 2.5%.
One should watch out for forex (gain/loss) in September quarter.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
